IP Library Granted Patent US 8,163,162
Granted Patent B2
US 8,163,162 · App. 11/278,341 · Granted Apr 24, 2012

Methods and apparatus for analyzing a sample in the presence of interferents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,162
App. No.
11/278,341
Granted
Apr 24, 2012
Kind
B2
Abstract

Disclosed herein are methods and apparatus for determining analyte concentration in a rapid and accurate manner. The methods include depositing a physiological sample in an electrochemical cell and finding a first and second current transient. Peak current values are obtained from the first and second peak current values and used to reduce the influence of interferents in a current value. Based on this “corrected” current value, an accurate analyte concentration can be determined.

Claims (103)

1. A method for reducing the effect of interferent in a test for analyte concentration, comprising:

(a) introducing a physiological sample into an electrochemical cell, the electrochemical cell comprising:

(i) first and second electrodes in a spaced apart relationship; and

(ii) a first reagent;

(b) applying a first test potential between said first and second electrodes, the first test potential having a first polarity and measuring cell current to obtain a first peak current value;

(c) applying a second test potential between said first and second electrodes, the second test potential having a second polarity, and measuring cell current to obtain a second peak current value;

(d) calculating an interference correction factor based on the first and second peak current values, wherein the interference correction factor can be used in a glucose concentration calculation to reduce the influence of chemical interferent compounds that will generate an interferent current by an oxidation or reduction reaction.

2. The method of claim 1 , wherein the step (c) further includes measuring cell current as a function of time to obtain a second current transient and calculating a first current value based on the second current transient.

3. The method of claim 2 , further comprising the step of calculating a corrected first current value by removing an interferent current value from the first current value.

4. The method of claim 3 , wherein the step of calculating a corrected first current value includes multiplying the first current value by an interferent correction equation, wherein the interferent correction equation is

{

i

pb

-

2

i

pa

+

i

ss

i

pb

+

i

ss

}

where i pb is the first peak current value, i pa is the second peak current value, and i ss is a steady-state current value.

5. The method of claim 4 , wherein the method further includes the steps of calculating a second current value based on the second current transient and measuring cell current as a function of time in step (b) to obtain a first current transient and calculating a third current value based on the first current transient.

6. The method of claim 5 , further comprising the step of calculating an analyte concentration based upon an equation

[

C

]

=

(

i

2

i

3

)

p

×

(

α

×

i

4

-

Z

)

where [C] is an analyte concentration, i 4 is the first correct current value, i 2 is the second current value, i 3 is the third current value, and a, p, and Z are calibration factors.

7. The method according to claim 1 , wherein the first reagent layer is disposed on the first electrode.

8. The method according to claim 7 , wherein the first polarity is negative with respect to the second electrode and the second polarity is positive with respect to the second electrode.

9. The method according to claim 8 , wherein a second reagent layer is disposed on the second electrode, wherein the second reagent layer comprises a redox mediator and is substantially free of the enzyme, and the redox mediator is capable of oxidizing an interferent present in the physiological sample.

10. The method of claim 1 , wherein step (c) further includes measuring cell current as a function of time to obtain a second current transient.

11. The method of claim 1 , wherein an analyte concentration is calculated based upon an equation

[

C

]

=

(

i

ss

i

pp

)

p

×

(

C

o

{

i

pb

-

2

i

pa

+

i

ss

i

pb

+

i

ss

}

-

Z

)

where [C] is an analyte concentration, i pp is a current value derived from the second current transient, C G is an estimated glucose concentration, i pa is the first peak current value, i pb is the second peak current value, and i SS is a steady state current value and Z is a calibration factor.

12. The method of claim 11 , wherein the term i pp is an average current over a short period of time near the end of the second current transient.

13. A method for reducing the effect of interferent in a test for analyte concentration, comprising:

(a) introducing a physiological sample into an electrochemical cell, the electrochemical cell comprising:

(i) a first reagent; and

(ii) two or more electrodes, the two or more electrodes consisting of a single working electrode and one or more other electrodes in a spaced apart relationship;

(b) applying a first test potential between the single working electrode and the one or more other electrodes, the first test potential having a first polarity, and measuring cell current to obtain a first peak current value;

(c) applying a second test potential between the single working electrode and the one or more other electrodes, the second test potential having a second polarity, and measuring cell current to obtain a second peak current value;

(d) calculating an interference correction factor based on the first and second peak current values, wherein the interference correction factor can be used in a glucose concentration calculation to reduce the influence of chemical interferent compounds that will generate an interferent current by an oxidation or reduction reaction.

14. The method of claim 13 , wherein the two or more electrodes consist of a single working electrode and a single reference electrode.

Assignments (22)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2018
From: AIA AMERICA, INC.
To: ARCHER PHARMACEUTICALS, INC.
Reel/Frame 046055/0704 →
QUITCLAIM ASSIGNMENT Recorded Jun 12, 2018
From: ARCHER PHARMACEUTICALS
To: LIFESCAN, INC.
Reel/Frame 046339/0144 →
QUITCLAIM ASSIGNMENT Recorded Jun 12, 2018
From: AIA AMERICA, INC.
To: LIFESCAN, INC.
Reel/Frame 046347/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2017
From: AIA AMERICA, INC.
To: ARCHER PHARMACEUTICALS, INC.
Reel/Frame 041233/0541 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Feb 13, 2017
From: ARCHER PHARMACEUTICALS, INC.
To: AIA AMERICA, INC.
Reel/Frame 041689/0945 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2006
From: CHATELIER, RONALD C.; HODGES, ALASTAIR MCINDOE; VERITY, BRUCE
To: LIFESCAN, INC.
Reel/Frame 017753/0001 →